Characterization of tumor microvascular structure and permeability: Comparison between magnetic resonance imaging and intravital confocal imaging

Journal of Biomedical Optics

Volumn 15, Issue 3, 2010, Pages

  Reitan, Nina Kristine ^a   Thuen, Marte ^a   Goa, Pål Erik ^b   De Lange Davies, Catharina ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Confocal laser scanning imaging; Dorsal window chamber; Magnetic resonance imaging; Permeability; Vasculature.

Indexed keywords

ABNORMAL BLOOD VESSELS; ATHYMIC MICE; CONCENTRATION-TIME; CONFOCAL IMAGING; CONFOCAL LASER SCANNING; CONFOCAL LASER SCANNING MICROSCOPY; CONTRAST AGENT; DCE-MRI; DORSAL WINDOW CHAMBER; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; HUMAN OSTEOSARCOMA; MICRO-VASCULATURE; MICROVASCULAR; MOLECULAR TRACER; NORMAL VESSELS; SOLID TUMORS; STRUCTURAL PARAMETER; TUMOR VASCULATURE; VASCULAR PERMEABILITY; VASCULATURE; VOLUME TRANSFER; WINDOW CHAMBERS;

BLOOD VESSELS; CONFOCAL MICROSCOPY; FRACTAL DIMENSION; LASER APPLICATIONS; MAMMALS; RESONANCE; TUMORS;

MAGNETIC RESONANCE IMAGING;

MUS; MUS MUSCULUS;

CONTRAST MEDIUM;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE TUMOR; CAPILLARY PERMEABILITY; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; DISEASE MODEL; FEMALE; HUMAN; METABOLISM; METHODOLOGY; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; OSTEOSARCOMA; PATHOLOGY; STATISTICAL MODEL; STRUCTURE ACTIVITY RELATION; VASCULARIZATION; XENOGRAFT;

ANIMALS; BONE NEOPLASMS; CAPILLARY PERMEABILITY; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSPLANTATION, HETEROLOGOUS;

EID: 79954481300     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3431095     Document Type: Article

References (51)

1. P. Vaupel and A. Mayer, "Hypoxia and anemia: effects on tumor biology and treatment resistance," Transfus. Clin. Biol. 12, 5-10 (2005). (Pubitemid 40487494)
2. D. Fukumura and R. K. Jain, "Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize," J. Cell. Biochem. 101, 937-949 (2007). (Pubitemid 47040874)
3. G. U. Dachs and D. J. Chaplin, "Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis," Semin. Radiat. Oncol. 8, 208-216 (1998). (Pubitemid 28323479)
4. R. K. Jain, "Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function," Cytokines Cell Mol. Ther. 74, 7-25 (2001). (Pubitemid 32727605)
5. S. H. Jang, M. G. Wientjes, D. Lu, and J. L.-S. Au, "Drug delivery and transport to solid tumors," Pharm. Res. 20, 1337-1350 (2003). (Pubitemid 37164040)
6. S. Kumar, A. Ghellal, C. Li, G. Byrne, N. Haboubi, J. M. Wang, and N. Bundred, "Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis," Cancer Res. 59, 856-861 (1999). (Pubitemid 29086739)
7. A. I. Minchinton and I. F. Tannock, "Drug penetration in solid tumours," Nat. Rev. Cancer 6, 583-592 (2006). (Pubitemid 44140857)
8. P. Sonveaux, C. Dessy, A. Brouet, B. H. Jordan, V. Grégoire, B. Gallez, J.-L. Balligand, and O. Feron, "Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery," FASEB J. 16, 1979- (2002).
9. P. Vaupel, F. Kallinowski, and P. Okunieff, "Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review," Cancer Res. 49, 6449-6465 (1989). (Pubitemid 20008770)
10. R. K. Jain, "Determinants of tumor blood-flow-a review," Cancer Res. 48, 2641-2658 (1988).
11. J. R. Less, T. C. Skalak, E. M. Sevick, and R. K. Jain, "Microvascular architecture in a mammary-carcinoma-branching patterns and vessel dimensions," Cancer Res. 51, 265-273 (1991).
12. M. Leunig, F. Yuan, M. D. Menger, Y. Boucher, A. E. Goetz, K. Messmer, and R. K. Jain, "Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma ls174t in scid mice," Cancer Res. 52, 6553-6560 (1992).
13. F. Yuan, "Transvascular drug delivery in solid tumors," Semin. Radiat. Oncol. 8, 164-175 (1998). (Pubitemid 28323475)
14. L. Eikenes, O. S. Bruland, C. Brekken, and C. de L. Davies, "Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts," Cancer Res. 64, 4768-4773 (2004). (Pubitemid 38930817)
15. Y. Boucher, L. T. Baxter, and R. K. Jain, "Interstitial pressure gradients in tissue-isolated and subcutaneous tumors-implications for therapy," Cancer Res. 50, 4478-4484 (1990). (Pubitemid 20230379)
16. H. Lyng, A. O. Vorren, K. Sundfør, I. Taksdal, H. H. Lien, O. Kaalhus, and E. K. Rofstad, "Intra- and intertumor heterogeneity in flood perfusion of human cervical cancer before treatment and after radiotherapy," Int. J. Cancer 96, 182-190 (2001). (Pubitemid 32520673)
17. D. Mancardi, G. Varetto, E. Bucci, F. Maniero, and C. Guiot, "Fractal parameters and vascular networks: facts and artifacts," Theor. Biol. Med. Mod. 5(1), 12 (2008).
18. J. W. Baish and R. K. Jain, "Fractals and cancer," Cancer Res. 60, 3683-3688 (2000). (Pubitemid 32204551)
19. E. Sabo, A. Boltenko, Y. Sova, A. Stein, S. Kleinhaus, and M. B. Resnick, "Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma," Clin. Cancer Res. 7, 533-537 (2001). (Pubitemid 32707975)
20. Y. Gazit, D. A. Berk, M. Leunig, L. T. Baxter, and R. K. Jain, "Scaleinvariant behavior and vascular network formation in normal and tumor tissue," Phys. Rev. Lett. 75, 2428-2431 (1995).
21. H. C. Roberts, M. Saeed, T. P. L. Roberts, A. Mühler, D. M. Shames, J. S. Mann, M. Stiskal, F. Demsar, and R. C. Brasch, "Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma," J. Magn. Reson Imaging 7, 331-338 (1997).
22. J. R. Ewing, S. L. Brown, M. Lu, S. Panda, G. Ding, R. A. Knight, Y. Cao, Q. Jiang, T. N. Nagaraja, J. L. Churchman, and J. D. Fenstermacher, "Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor," J. Cereb. Blood Flow Metab. 26, 310-320 (2006).
23. M. Verhoye, B. P. J. van der Sanden, P. F. J. W. Rijken, H. P. W. Peters, A. J. Van der Kogel, G. Pee, G. Vanhoutte, A. Heerschap, and A. Van der Linden, "Assessment of the neovascular permeability in glioma xenografts by dynamic T-1 MRI with Gadomer-17," Magn. Reson. Med. 47, 305-313 (2002). (Pubitemid 34116799)
24. P. S. Tofts, G. Brix, D. L. Buckley, J. L. Evelhoch, E. Henderson, M. V. Knopp, H. B. W. Larsson, T.-Y. Lee, N. A. Mayr, G. J. M. Parker, R. E. Port, J. Taylor, and R. M. Weisskoff, "Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent," J. Magn. Reson Imaging 10, 223-232 (1999).
25. R. Weissleder and M. J. Pittet, "Imaging in the era of molecular oncology," Nature 452, 580-589 (2008). (Pubitemid 351483372)
26. A. Erikson, I. Tufto, A. B. Bjønnum, O. S. Bruland, and C. de L. Davies, "The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules," Anticancer Res. 28, 3557-3566 (2008).
27. O. Fodstad, A. Brøgger, O. Bruland, O. P. Solheim, J. M. Nesland, and A. Pihl, "Characteristics of a cell-line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma," Int. J. Cancer 38, 33-40 (1986). (Pubitemid 16056255)
28. B. Misselwitz, H. Schmitt-Willich, W. Ebert, T. Frenzel, and H. J. Weinmann, "Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent," Magn. Reson. Mater. Phys., Biol., Med. 12, 128-134 (2001). (Pubitemid 32510131)
29. H. J. Weinmann, W. Ebert, B. Misselwitz, and H. Schmitt-Willich, "Tissue-specific MR contrast agents," Eur. J. Radiol. 46, 33-44 (2003). (Pubitemid 36332077)
30. M. D. Ogan, "Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization," Invest. Radiol. 23, 961-961 (1988).
31. C. S. Patlak, R. G. Blasberg, and J. D. Fenstermacher, "Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data," J. Cereb. Blood Flow Metab. 3, 1-7 (1983). (Pubitemid 13129630)
32. C. C. Reyes-Aldasoro, I. Wilson, V. E. Prise, P. R. Barber, S. M. Ameer-Beg, B. Vojnovic, V. J. Cunningham, and G. M. Tozer, "Estimation of apparent tumor vascular permeability from multiphoton fluorescence microscopic images of P22 rat sarcomas in vivo," Microcirculation 15, 65-79 (2008).
33. U. Bickel, "How to measure drug transport across the blood-brain barrier," Neurotherapeutics 2, 15-26 (2005). (Pubitemid 40128023)
34. Bayer Schering Pharma AG, Berlin, Private Communication (2009).
35. M. Verhoye, P. J. van der S. Boudewijn, P. Rijken, H. Peters, A. J. Van der Kogel, G. Pée, G. Vanhoutte, A. Heerschap, and A. Van der Linden, "Quantification of tumor microvascular permeability in human glioma xenografts using dynamic T1 MRI with Gadomer-17," Proc. SPIE 3660, 418-428 (1999).
36. N. Weidner, J. Folkman, F. Pozza, P. Bevilacqua, E. N. Allred, D. H. Moore, S. Meli, and G. Gasparini, "Tumor angiogenesis-a new significant and independent prognostic indicator in early-stage breast carcinoma," J. Natl. Cancer Inst. 84, 1875-1887 (1992). (Pubitemid 23004615)
37. P. B. Vermeulen, D. Verhoeven, G. Hubens, E. Vanmarck, G. Goovaerts, M. Huyghe, E. A. Debruijn, A. T. Vanoosterom, and L. Y. Dirix, "Microvessel density, endothelial-cell proliferation and tumorcell proliferation in human colorectal adenocarcinomas," Ann. Oncol. 6, 59-64 (1995).
38. L. M. Ellis, Y. Takahashi, C. J. Fenoglio, K. R. Cleary, C. D. Bucana, and D. B. Evans, "Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma," Eur. J. Cancer 34, 337-340 (1998). (Pubitemid 28183830)
39. I. G. Duarte, B. L. Bufkin, M. F. Pennington, A. A. Gal, C. Cohen, A. S. Kosinski, K. A. Mansour, and J. I. Miller, "Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer," J. Thorac. Cardiovasc. Surg. 115, 652-658 (1998).
40. Y. Tsuzuki, D. Fukumura, B. Oosthuyse, C. Koike, P. Carmeliet, and R. K. Jain, "Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1 alpha → hypoxia response element → VEGF cascade differentially regulates vascular response and growth rate in tumors, Cancer Res. 60, 6248-6252 (2000).
41. F. Yuan, Y. Chen, M. Dellian, N. Safabakhsh, N. Ferrara, and R. K. Jain, Quantification of tumor microvascular permeability in human glioma xenografts using dynamic T1 MRI with Gadomer-17, Proc. Natl. Acad. Sci. U.S.A. 93, 14765-14770 (1996).
42. J. V. Gaustad, K. G. Brurberg, T. G. Simonsen, C. S. Mollatt, and E. K. Rofstad, Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging, Neoplasia 10, 354.362 (2008). (Pubitemid 351483575)
43. R. Duncan and L. Izzo, Dendrimer biocompatibility and toxicity, Adv. Drug Delivery Rev. 57, 2215.2237 (2005). (Pubitemid 41759394)
44. M. Y. Su, A. Muhler, X. Lao, and O. Nalcioglu, Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights, Magn. Reson. Med. 39, 259. 269 (1998).
45. M. R. Dreher, W. G. Liu, C. R. Michelich, M. W. Dewhirst, F. Yuan, and A. Chilkoti, Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers, J. Natl. Cancer Inst. 98, 335-344 (2006). (Pubitemid 43338213)
46. H. F. Dvorak, J. A. Nagy, J. T. Dvorak, and A. M. Dvorak, Identification and characterization of the blood-vessels of solid tumors that are leaky to circulating macromolecules, Am. J. Pathol. 133, 95-109 (1988).
47. R. K. Jain, Vascular and interstitial barriers to delivery of therapeutic agents in tumors, Cancer Metastasis Rev. 9, 253-266 (1990). (Pubitemid 20380382)
48. M. Dellian, F. Yuan, V. S. Trubetskoy, V. P. Torchilin, and R. K. Jain, Vascular permeability in a human tumour xenograft: molecular charge dependence, Br. J. Cancer 82, 1513-1518 (2000). (Pubitemid 30204355)
49. C. Nguyen-Minh, V. M. Haughton, H. S. An, J. W. You, S. Wook, and K.-C. Ho, Contrast media of high and low molecular weights in the detection of recurrent herniated disks, AJNR Am. J. Neuroradiol. 19, 889-893 (1998). (Pubitemid 30415772)
50. J. A. Nagy, E. Vasile, D. Feng, X. Sundberg, L. F. Brown, M. J. Detmar, J. A. Lawitts, L. Benjamin, X. Tan, E. J. Manseau, A. M. Dvorak, and H. F. Dvorak, Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis, J. Exp. Med. 196, 1497-1506 (2002). (Pubitemid 35424943)
51. M. M. Pike, C. N. Stoops, C. P. Langford, N. S. Akella, L. B. Nabors, and G. Y. Gillespie, High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: sequential small molecule and SPIO dynamic contrast agent MRI, Magn. Reson. Med. 61, 615-625 (2009).